Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
The Journal of Rheumatology|September 17, 2018
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus ErythematosusChristine A Peschken, Yishu Wang, Michal Abrahamowicz, et al.Human Molecular Genetics|January 30, 2022
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositisClaire T Deakin, John Bowes, Lisa G Rider, et al.Arthritis and Rheumatism|May 18, 2004
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Brian M Feldman, Robert M Rennebohm, et al.Arthritis Care & Research|October 16, 2018
Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes CohortJennifer J Y Lee, Ciarán M Duffy, Jaime Guzman, et al.Arthritis Care & Research|November 15, 2011
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conferenceAdam M Huber, Angela B Robinson, Ann M Reed, et al.Arthritis and Rheumatism|June 10, 2004
Normal scores for nine maneuvers of the Childhood Myositis Assessment ScaleRobert M Rennebohm, Karla Jones, Adam M Huber, et al.The Journal of Rheumatology|January 17, 2019
Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out CohortJaime Guzman, Andrew Henrey, Thomas Loughin, et al.Arthritis Care & Research|June 27, 2024
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile DermatomyositisStacey E Tarvin, Matthew A Sherman, Hanna Kim, et al.Rheumatology (Oxford, England)|January 20, 2024
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registryDaniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2015
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic DisordersClaire M A LeBlanc, Jinhui Ma, Monica Taljaard, et al.Pageof 11